Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women.

Anderson GD, Elmer GW, Taibi DM, Vitiello MV, Kantor E, Kalhorn TF, Howald WN, Barsness S, Landis CA.

Phytother Res. 2010 Oct;24(10):1442-6. doi: 10.1002/ptr.3151.

PMID:
20878691
2.

Estrogen biodegradation kinetics and estrogenic activity reduction for two biological wastewater treatment methods.

Gaulke LS, Strand SE, Kalhorn TF, Stensel HD.

Environ Sci Technol. 2009 Sep 15;43(18):7111-6.

PMID:
19806750
3.

Serum LH correlates highly with intratesticular steroid levels in normal men.

Roth MY, Lin K, Amory JK, Matsumoto AM, Anawalt BD, Snyder CN, Kalhorn TF, Bremner WJ, Page ST.

J Androl. 2010 Mar-Apr;31(2):138-45. doi: 10.2164/jandrol.109.008391. Epub 2009 Sep 24.

4.

Estrogen nitration kinetics and implications for wastewater treatment.

Gaulke LS, Strand SE, Kalhorn TF, Stensel HD.

Water Environ Res. 2009 Aug;81(8):772-8.

PMID:
19774854
5.

Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity.

Xia L, Zhou M, Kalhorn TF, Ho HT, Wang J.

Am J Physiol Renal Physiol. 2009 Jun;296(6):F1307-13. doi: 10.1152/ajprenal.00046.2009. Epub 2009 Apr 8.

6.

A sensitive liquid chromatography/mass spectrometry-based assay for quantitation of amino-containing moieties in lipid A.

Kalhorn TF, Kiavand A, Cohen IE, Nelson AK, Ernst RK.

Rapid Commun Mass Spectrom. 2009 Feb;23(3):433-42. doi: 10.1002/rcm.3900.

7.

17alpha-ethinylestradiol transformation via abiotic nitration in the presence of ammonia oxidizing bacteria.

Gaulke LS, Strand SE, Kalhorn TF, Stensel HD.

Environ Sci Technol. 2008 Oct 15;42(20):7622-7.

PMID:
18983084
8.

Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.

Smith HE, Jones JP 3rd, Kalhorn TF, Farin FM, Stapleton PL, Davis CL, Perkins JD, Blough DK, Hebert MF, Thummel KE, Totah RA.

Pharmacogenet Genomics. 2008 Nov;18(11):943-53. doi: 10.1097/FPC.0b013e32830e1e16.

9.

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.

Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS.

Cancer Res. 2008 Jun 1;68(11):4447-54. doi: 10.1158/0008-5472.CAN-08-0249.

10.

Identification of human UDP-glucuronosyltransferases catalyzing hepatic 1alpha,25-dihydroxyvitamin D3 conjugation.

Hashizume T, Xu Y, Mohutsky MA, Alberts J, Hadden C, Kalhorn TF, Isoherranen N, Shuhart MC, Thummel KE.

Biochem Pharmacol. 2008 Mar 1;75(5):1240-50. doi: 10.1016/j.bcp.2007.11.008. Epub 2007 Nov 22.

12.
13.

Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment.

Page ST, Kalhorn TF, Bremner WJ, Anawalt BD, Matsumoto AM, Amory JK.

J Androl. 2007 Sep-Oct;28(5):734-41. Epub 2007 May 9.

14.

Determination of free and total cortisol in plasma and urine by liquid chromatography-tandem mass spectrometry.

Huang W, Kalhorn TF, Baillie M, Shen DD, Thummel KE.

Ther Drug Monit. 2007 Apr;29(2):215-24.

PMID:
17417077
15.

Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography-mass spectrometry.

Kalhorn TF, Howald WN, Cole S, Phillips B, Wang J, Slattery JT, McCune JS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 1;835(1-2):105-13. Epub 2006 Apr 11.

PMID:
16581318
16.

Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia.

Xu Y, Hashizume T, Shuhart MC, Davis CL, Nelson WL, Sakaki T, Kalhorn TF, Watkins PB, Schuetz EG, Thummel KE.

Mol Pharmacol. 2006 Jan;69(1):56-65. Epub 2005 Oct 5.

PMID:
16207822
17.

Metabolism-based cyclophosphamide dosing for hematopoietic cell transplant.

McDonald GB, McCune JS, Batchelder A, Cole S, Phillips B, Ren AG, Vicini P, Witherspoon R, Kalhorn TF, Slattery JT.

Clin Pharmacol Ther. 2005 Sep;78(3):298-308.

PMID:
16153400
18.

A highly sensitive high-performance liquid chromatography-mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells.

Kalhorn TF, Ren AG, Slattery JT, McCune JS, Wang J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jun 25;820(2):243-50. Epub 2005 Apr 21.

PMID:
15899377
19.

Frequency of soy food consumption and serum isoflavone concentrations among Chinese women in Shanghai.

Frankenfeld CL, Lampe JW, Shannon J, Gao DL, Ray RM, Prunty J, Kalhorn TF, Wähälä K, Patterson RE, Thomas DB.

Public Health Nutr. 2004 Sep;7(6):765-72.

PMID:
15369615
20.

ABCC2-mediated biliary transport of 4-glutathionylcyclophosphamide and its contribution to elimination of 4-hydroxycyclophosphamide in rat.

Qiu R, Kalhorn TF, Slattery JT.

J Pharmacol Exp Ther. 2004 Mar;308(3):1204-12. Epub 2003 Nov 14.

PMID:
14617693
21.

Transiently altered acetaminophen metabolism after liver transplantation.

Park JM, Lin YS, Calamia JC, Thummel KE, Slattery JT, Kalhorn TF, Carithers RL Jr, Levy AE, Marsh CL, Hebert MF.

Clin Pharmacol Ther. 2003 Jun;73(6):545-53.

PMID:
12811364
22.

Effect of route of administration on the pharmacokinetic behavior of enantiomers of nefopam and desmethylnefopam.

Chawla J, Le Guern ME, Alquier C, Kalhorn TF, Levy RH.

Ther Drug Monit. 2003 Apr;25(2):203-10.

PMID:
12657915
23.

Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women.

Frankenfeld CL, Patterson RE, Horner NK, Neuhouser ML, Skor HE, Kalhorn TF, Howald WN, Lampe JW.

Am J Clin Nutr. 2003 Mar;77(3):674-80.

PMID:
12600860
24.

Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19.

Lakehal F, Wurden CJ, Kalhorn TF, Levy RH.

Epilepsy Res. 2002 Dec;52(2):79-83.

PMID:
12458024
25.

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation.

McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn TF, Schoch HG, Anasetti C, Gooley T.

Blood. 2003 Mar 1;101(5):2043-8. Epub 2002 Oct 24.

PMID:
12406916
26.

Validation of a soy food frequency questionnaire with plasma concentrations of isoflavones in US adults.

Frankenfeld CL, Patterson RE, Kalhorn TF, Skor HE, Howald WN, Lampe JW.

J Am Diet Assoc. 2002 Oct;102(10):1407-13.

PMID:
12396157
27.

Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver.

Zhao P, Kalhorn TF, Slattery JT.

Hepatology. 2002 Aug;36(2):326-35.

PMID:
12143040
28.
29.

Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation.

Manyike PT, Kharasch ED, Kalhorn TF, Slattery JT.

Clin Pharmacol Ther. 2000 Mar;67(3):275-82.

PMID:
10741631
30.

Analysis of cyclophosphamide and five metabolites from human plasma using liquid chromatography-mass spectrometry and gas chromatography-nitrogen-phosphorus detection.

Kalhorn TF, Ren S, Howald WN, Lawrence RF, Slattery JT.

J Chromatogr B Biomed Sci Appl. 1999 Sep 24;732(2):287-98.

PMID:
10517350
31.

Inhibition of human aldehyde dehydrogenase 1 by the 4-hydroxycyclophosphamide degradation product acrolein.

Ren S, Kalhorn TF, Slattery JT.

Drug Metab Dispos. 1999 Jan;27(1):133-7.

PMID:
9884322
32.

Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients.

Ren S, Kalhorn TF, McDonald GB, Anasetti C, Appelbaum FR, Slattery JT.

Clin Pharmacol Ther. 1998 Sep;64(3):289-301.

PMID:
9757153
33.

Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits.

Scism JL, Powers KM, Artru AA, Chambers AC, Lewis L, Adkison KK, Kalhorn TF, Shen DD.

Drug Metab Dispos. 1997 Dec;25(12):1337-46.

PMID:
9394022
34.
35.

Characterization of carbamazepine metabolism in a mouse model of carbamazepine teratogenicity.

Amore BM, Kalhorn TF, Skiles GL, Hunter AP, Bennett GD, Finnell RH, Nelson SD, Slattery JT.

Drug Metab Dispos. 1997 Aug;25(8):953-62.

PMID:
9280403
36.

Teratogenicity of carbamazepine-10, 11-epoxide and oxcarbazepine in the SWV mouse.

Bennett GD, Amore BM, Finnell RH, Wlodarczyk B, Kalhorn TF, Skiles GL, Nelson SD, Slattery JT.

J Pharmacol Exp Ther. 1996 Dec;279(3):1237-42.

PMID:
8968346
37.

Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol.

Lillibridge JA, Kalhorn TF, Slattery JT.

Drug Metab Dispos. 1996 Nov;24(11):1174-9.

PMID:
8937849
38.

Protein-reactive metabolites of carbamazepine in mouse liver microsomes.

Lillibridge JH, Amore BM, Slattery JT, Kalhorn TF, Nelson SD, Finnell RH, Bennett GD.

Drug Metab Dispos. 1996 May;24(5):509-14.

PMID:
8723729
39.

Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients.

Slattery JT, Kalhorn TF, McDonald GB, Lambert K, Buckner CD, Bensinger WI, Anasetti C, Appelbaum FR.

J Clin Oncol. 1996 May;14(5):1484-94.

PMID:
8622062
40.

Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers.

Mitra AK, Thummel KE, Kalhorn TF, Kharasch ED, Unadkat JD, Slattery JT.

Clin Pharmacol Ther. 1996 Mar;59(3):332-40.

PMID:
8653996
41.

Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo.

Mitra AK, Thummel KE, Kalhorn TF, Kharasch ED, Unadkat JD, Slattery JT.

Clin Pharmacol Ther. 1995 Nov;58(5):556-66.

PMID:
7586950
43.

Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans.

Zand R, Nelson SD, Slattery JT, Thummel KE, Kalhorn TF, Adams SP, Wright JM.

Clin Pharmacol Ther. 1993 Aug;54(2):142-9.

PMID:
8354023
44.

Activation of acetaminophen-reactive metabolite formation by methylxanthines and known cytochrome P-450 activators.

Lee CA, Thummel KE, Kalhorn TF, Nelson SD, Slattery JT.

Drug Metab Dispos. 1991 Sep-Oct;19(5):966-71.

PMID:
1686244
45.

Mechanisms by which acetaminophen administration diminishes ethanol clearance.

Slattery JT, Kalhorn TF, Thummel KE.

Drug Metab Dispos. 1991 Mar-Apr;19(2):558-60. No abstract available.

PMID:
1676670
46.

Inhibition and activation of acetaminophen reactive metabolite formation by caffeine. Roles of cytochromes P-450IA1 and IIIA2.

Lee CA, Thummel KE, Kalhorn TF, Nelson SD, Slattery JT.

Drug Metab Dispos. 1991 Mar-Apr;19(2):348-53.

PMID:
1676635
47.

Inhibition of the metabolism of paracetamol by isoniazid.

Epstein MM, Nelson SD, Slattery JT, Kalhorn TF, Wall RA, Wright JM.

Br J Clin Pharmacol. 1991 Feb;31(2):139-42.

48.

Effect of methylxanthines on acetaminophen hepatotoxicity in various induction states.

Kalhorn TF, Lee CA, Slattery JT, Nelson SD.

J Pharmacol Exp Ther. 1990 Jan;252(1):112-6.

PMID:
2299585
49.

Lack of effect of cimetidine on acetaminophen disposition in humans.

Slattery JT, McRorie TI, Reynolds R, Kalhorn TF, Kharasch ED, Eddy AC.

Clin Pharmacol Ther. 1989 Nov;46(5):591-7.

PMID:
2582712

Supplemental Content

Loading ...
Support Center